Page 53 - Quest Diagnostics News Today

The settlement includes Sacramento, San Joaquin, and Yolo counties

Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The

HOUSTON, TX - Eastham Capital, a private equity real estate firm dedicated to providing superior, risk-adjusted returns to investors through the transformation of undervalued multifamily real estate, has partnered with Mosaic Residential, a Houston-based multifamily owner-operator in the acquisition of Sola Westchase, a 318-unit residential community located in the Westchase submarket of Houston, Texas. South Florida-based Eastham Capital has invested in the deal through its current fund,...

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nations leading provider of diagnostic information services, today announced the launch of MelaNodal...

Quest Diagnostics (NYSE: DGX) watched its shares move earthward Tuesday, as the leading U.S. provider of diagnostic information services, today announced the launch of MelaNodal Predict™, a highly advanced predictive gene expression test to help personalize ...

The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...

Quest Diagnostics announces an algorithm-assisted test for oncology care teams, and KeyCare partners with WellSpan Health to expand virtual care access.

In the face of complex, complicated healthcare revenue cycles, RCM companies provide cutting-edge solutions to simplify the process.

Andra AP fonden reduced its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 33.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,500 shares of the medical research company’s stock after selling 24,900 shares during the quarter. Andra […]

/PRNewswire/ -- The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets" report has been added to ResearchAndMarkets.coms offering....